ID

28402

Beschreibung

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Liver events

Stichworte

  1. 11.10.17 11.10.17 -
  2. 16.10.17 16.10.17 -
  3. 16.10.17 16.10.17 -
  4. 23.10.17 23.10.17 -
  5. 11.01.18 11.01.18 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

11. Januar 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Liver events GSK study Chronic Coronary Heart Disease NCT00799903

Liver events GSK study Chronic Coronary Heart Disease NCT00799903

1. Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?
Beschreibung

1. Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?

[1] ALT (alanine aminotransferase)
Beschreibung

alanine aminotransferase

Datentyp

boolean

Alias
UMLS CUI [1]
C0201836
[2] AST (aspartate aminotransferase)
Beschreibung

aspartate aminotransferase

Datentyp

boolean

Alias
UMLS CUI [1]
C0201899
[3] Total bilirubin
Beschreibung

Total bilirubin

Datentyp

boolean

Alias
UMLS CUI [1]
C0201913
[4] Alkaline phosphatase
Beschreibung

Alkaline phosphatase

Datentyp

boolean

Alias
UMLS CUI [1]
C0201850
[OT] Other
Beschreibung

Other liver chemistry result

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0008000
UMLS CUI [1,2]
C0587081
Liver events
Beschreibung

Liver events

2. Is the subject age 55 or older?
Beschreibung

subject age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
3. If female, is the subject pregnant?
Beschreibung

If yes, ensure Pregnancy Notification Form has been completed.

Datentyp

text

Alias
UMLS CUI [1]
C0549206
4. Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as liver ultrasound, computerised tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
Beschreibung

diagnostic imaging of liver or hepatobiliary system

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1711359
UMLS CUI [1,2]
C0011923
UMLS CUI [1,3]
C0023884
4. If diagnostic imaging tests were performed, were the results normal?
Beschreibung

If No, record the details on the Non-Serious Adverse Events form or Serious Adverse Event form.

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1711359
UMLS CUI [1,2]
C0011923
UMLS CUI [1,3]
C0023884
UMLS CUI [1,4]
C1254595
5. Were any liver biopsies performed?
Beschreibung

If yes, complete Liver Biopsy form.

Datentyp

boolean

Alias
UMLS CUI [1]
C0193388
6. Does the subject use herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
Beschreibung

If yes, record on the appropriate Concomitant Medication form.

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0002346
UMLS CUI [1,2]
C0242295
UMLS CUI [1,3]
C0281875
7. Did the subject fast or undergo significant dietary change in the past week?
Beschreibung

dietary change

Datentyp

boolean

Alias
UMLS CUI [1]
C3671772
Evaluation interval code
Beschreibung

[hidden]

Datentyp

text

Alias
UMLS CUI [1]
C2985767

Ähnliche Modelle

Liver events GSK study Chronic Coronary Heart Disease NCT00799903

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
1. Which liver chemistry result reached or exceeded protocol-defined investigational product stopping criteria?
alanine aminotransferase
Item
[1] ALT (alanine aminotransferase)
boolean
C0201836 (UMLS CUI [1])
aspartate aminotransferase
Item
[2] AST (aspartate aminotransferase)
boolean
C0201899 (UMLS CUI [1])
Total bilirubin
Item
[3] Total bilirubin
boolean
C0201913 (UMLS CUI [1])
Alkaline phosphatase
Item
[4] Alkaline phosphatase
boolean
C0201850 (UMLS CUI [1])
Other liver chemistry result
Item
[OT] Other
boolean
C0008000 (UMLS CUI [1,1])
C0587081 (UMLS CUI [1,2])
Item Group
Liver events
subject age
Item
2. Is the subject age 55 or older?
boolean
C0001779 (UMLS CUI [1])
Item
3. If female, is the subject pregnant?
text
C0549206 (UMLS CUI [1])
Code List
3. If female, is the subject pregnant?
CL Item
Yes (Y)
CL Item
No (N)
CL Item
Not applicable (X)
diagnostic imaging of liver or hepatobiliary system
Item
4. Were any diagnostic imaging tests of the liver or hepatobiliary system performed (such as liver ultrasound, computerised tomography or CAT scan, magnetic resonance imaging or MRI, or endoscopic retrograde cholangiopancreatography, or other)?
boolean
C1711359 (UMLS CUI [1,1])
C0011923 (UMLS CUI [1,2])
C0023884 (UMLS CUI [1,3])
diagnostic imaging of liver or hepatobiliary system results
Item
4. If diagnostic imaging tests were performed, were the results normal?
boolean
C1711359 (UMLS CUI [1,1])
C0011923 (UMLS CUI [1,2])
C0023884 (UMLS CUI [1,3])
C1254595 (UMLS CUI [1,4])
liver biopsies
Item
5. Were any liver biopsies performed?
boolean
C0193388 (UMLS CUI [1])
complementary or alternative medicines, supplements, illicit drugs
Item
6. Does the subject use herbals, complementary or alternative medicines, food supplements (vitamins) or illicit drugs?
boolean
C0002346 (UMLS CUI [1,1])
C0242295 (UMLS CUI [1,2])
C0281875 (UMLS CUI [1,3])
dietary change
Item
7. Did the subject fast or undergo significant dietary change in the past week?
boolean
C3671772 (UMLS CUI [1])
Evaluation interval code
Item
Evaluation interval code
text
C2985767 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video